Treating Oligometastatic Prostate Cancer in the PSMA PET Era
Andrew W. Hahn, MD, addresses the treatment of oligometastatic prostate cancer in the PSMA PET era from a medical oncology perspective.
Read MoreSelect Page
Posted by Andrew W. Hahn, MD | May 2025
Andrew W. Hahn, MD, addresses the treatment of oligometastatic prostate cancer in the PSMA PET era from a medical oncology perspective.
Read MorePosted by Brian J. Flynn, MD | May 2025
Brian J. Flynn, MD, explores advancements in treating male stress urinary incontinence, and the shift toward passive and adjustable devices.
Read MorePosted by R. Jonathan Henderson, MD | May 2025
R. Jonathan Henderson, MD, examines prostate cancer screening, emphasizing key trials and ongoing global efforts to improve detection.
Read MorePosted by Sung Yong Cho, MD, MS, Phd | May 2025
Sung Youg Cho, MD, MS, PhD, explores single-use digital flexible ureteroscopes for endoscopic stone surgery.
Read MorePosted by Steven J. Frank, MD, FACR, FABS, FASTRO | May 2025
Steven J. Frank, MD, FACR, FABS, FASTRO, discusses advancements in MRI-assisted radiosurgery (MARS) for prostate cancer.
Read More